Practice
Featured experience
Bristol Myers Squibb €5 billion notes offering
We advised the underwriters on Bristol Myers Squibb Ireland’s inaugural euro issuance
BETA Technologies $1 billion IPO
The shares are listed on the New York Stock Exchange
Vistra $2 billion secured notes offering
The investment-grade notes are due 2028, 2030 and 2035
American Industrial Partners $1.5 billion acquisition of Global Cellulose Fibers
We are advising American Industrial Partners on the transaction
Granite $373.75 million convertible senior notes and capped call transactions
The 3.75% convertible senior notes are due 2028
Hayward Holdings $286 million secondary offering
The stock is listed on the New York Stock Exchange
Beyond Meat $200 million at-the-market offering
The stock offering is SEC-registered
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
Clarios $750 million notes offering and $2.75 billion term loan
We advised Clarios International on the transactions
Advent International $2.25 billion Maxar Technologies acquisition financing
We advised the lenders on the facilities
Constellation Brands $750 million senior notes offering
The investment-grade notes are due 2033
PGE $300 million at-the-market offering
The common stock is listed on the NYSE
Canadian Pacific Railway $3 billion exchange offers and consent solicitations
The exchange offers and consent solicitations are for senior notes
Valaris $700 million senior secured second-lien notes offering
The high-yield senior secured second-lien notes are due 2030